Constellation 3D Announces Appointment of Dr. Jesse Fussell; Former ARDA Director to Join Newly Created Scientific Advisory Board.Business Editors NEW YORK--(BUSINESS WIRE)--May 7, 2001 Constellation 3D, Inc. ("C3D C3D - Constellation 3D, Inc") (Nasdaq/NMS: CDDD CDDD - Component Detailed Design Document CDDD - Construction and Demolition Diversion Deposit CDDD - Customer Desired Due Date), developer of Fluorescent Multilayer Discs (FMD FMD - Facilities Management Design, Ltd. (UK) FMD - Facilities Management Division FMD - Facioscapulohumeral Muscular Dystrophy FMD - Farm Management Deposits (Australia) FMD - Fault Manager Diagnostic FMD - Ferry Movement Directive FMD - Fibromuscular Dysplasia (arterial disease) FMD - Field Monitoring Device (electronic home arrest equipment) FMD - Financial Management Division FMD - Fleet Maintenance Data FMD - Florida Mainstream Democrats) and Cards (FMC), today announced the appointment of Dr. Jesse Fussell and the formation of a Scientific Advisory Board which will supervise the FMD/C (Fluorescent Multilayer Disk/Card) An optical storage technology from Constellation 3D Inc., New York, that offered a dramatic increase in capacity, but never became a commercial success. An FMD disk was expected to have the capacity of 200 CD-ROMs or 15 dual-layer DVDs. Read-only, write-once and recordable disks, smart cards and flash card-sized modules were also planned. standardization program. Dr. Fussell was the founder and first Director of ARDA ARDA - Active Retro-Directive Array ARDA - Adaptive Rate Decision Algorithm (Sprint) ARDA - Advanced Research and Development Activity (US government; now Disruptive Technology Office, DTO) ARDA - Advanced Research and Development Agency ARDA - Airborne Radar Directed Approach ARDA - American Religion Data Archive ARDA - American Rescue Dog Association ARDA - American Resort Development Association ARDA - Atomic Research and Development Authority (Advance Research and Development Activity), an information technology agency of the US government. He was responsible for the funding and incubation of many innovative technology companies under ARDA's operating mandate. Further, Dr. Fussell directed the communications science research division of the NSA (National Security Agency) and has been involved in furthering relationships between the high technology industry and US government for over 20 years. "C3D's revolutionary Fluorescent Multilayer technology has tremendous potential and I look forward to helping ensure that its value is realized in commercial and government applications," said Dr. Fussell. "Dr. Fussell is a respected industry leader and we are very excited to have him join us," said C3D President and CEO Dr. Eugene Levich. "In addition, the establishment of a Scientific Advisory Board gives us a vehicle to draw from a vast knowledge base of industry experts from outside of the Company. The Board's first task will be to supervise the implementation of a comprehensive FMD standardization program." Constellation 3D, Inc. The Company is the worldwide leader in the development of high capacity Fluorescent Multilayer Disc and Card (FMD/C) technology. Constellation 3D holds or has made applications for over 80 worldwide patents in the field of optical data storage, and is supported by 65 scientists. Headquartered in New York City, the Company has additional offices and laboratories in Massachusetts, Israel and Russia. More information is available at www.c-3d.net. Safe Harbor Statement Statements contained in the news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements as "I look forward to helping ensure that its value is realized in commercial and government applications" and "C3D's revolutionary fluorescent multilayer technology has tremendous potential" are subject to risks and uncertainties including competition, ongoing discussions with product and equipment manufactures, and technological advances, and "Risk Factors" as stated in recent SEC filings, which may cause actual results to differ materially from expected results. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion